The potential role for romidepsin as a component in early HIV-1 curative efforts

Expert Rev Anti Infect Ther. 2016;14(5):447-50. doi: 10.1586/14787210.2016.1164031. Epub 2016 Mar 24.

Authors

Jesper Damsgaard Gunst^{1

2}, Martin Tolstrup¹, Thomas Aagaard Rasmussen¹, Ole Schmeltz Søgaard^{1

2}

Affiliations

¹ a Department of Infectious Diseases , Aarhus University Hospital , Aarhus N , Denmark.
² b Institute of Clinical Medicine , Aarhus University , Aarhus N , Denmark.

PMID: 26953620
DOI: 10.1586/14787210.2016.1164031

No abstract available

Keywords: HIV cure; HIV persistence; Histone deacetylase inhibitors; Immunotherapy; Romidepsin.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Anti-HIV Agents / pharmacology
Anti-HIV Agents / therapeutic use
Depsipeptides / pharmacology
Depsipeptides / therapeutic use*
Gene Expression / drug effects
HIV Infections / drug therapy*
HIV Infections / prevention & control
HIV-1 / drug effects
HIV-1 / physiology
Humans

Substances

Anti-HIV Agents
Depsipeptides
romidepsin